Turkish league against rheumatism national recommendations for the management of ankylosing spondylitis

dc.contributor.authorBodur, Hatice
dc.contributor.authorSivas, Filiz
dc.contributor.authorYılmaz, Özlem
dc.contributor.authorÖzgöçmen, Salih
dc.contributor.authorGünaydın, Rezzan
dc.contributor.authorKaya, Tacıser
dc.contributor.authorAtaman, Şebnem
dc.contributor.authorAltay, Zuhal
dc.contributor.authorAydoğ, Ece
dc.contributor.authorBirtane, Murat
dc.contributor.authorBorman, Pınar
dc.contributor.authorBuğdaycı, Derya Soy
dc.contributor.authorBütün, Bülent
dc.contributor.authorÇakırbay, Haşim
dc.contributor.authorDuruöz, Tuncay
dc.contributor.authorGürer, Gülcan
dc.contributor.authorHepgüler, Simin
dc.contributor.authorKamanlı, Ayhan
dc.contributor.authorKuru, Ömer
dc.contributor.authorKüçükdeveci, Ayşe
dc.contributor.authorNacir, Barış
dc.contributor.authorÖlmez, Neşe
dc.contributor.authorRezvani, Aylin
dc.contributor.authorYanık, Burcu Çörekçi
dc.contributor.buuauthorAltan, Lale
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı.tr_TR
dc.contributor.researcheridAAH-1652-2021tr_TR
dc.contributor.scopusid6603281363tr_TR
dc.date.accessioned2022-03-16T08:06:29Z
dc.date.available2022-03-16T08:06:29Z
dc.date.issued2011
dc.description.abstractObjectives: To develop Turkish League Against Rheumatism (TLAR) National Recommendations for the management of ankylosing spondylitis (AS). Materials and methods: A scientific committee of 25 experts consisting of six rheumatologists and 19 physical medicine and rehabilitation specialists was formed by TLAR. Recommendations were based on the 2006 ASsessment in Ankylosing Spondylitis International Working Group(ASAS)/European League Against Rheumatism (EULAR) recommendations and a systematic review of associated publications between January 2005 and September 2010. A Delphi process was used to develop the recommendations. Twelve major recommendations were constructed for the management of AS. Voting using a numerical rating scale assessed the strength of each recommendation. Results: The 12 recommendations include patient assessment, patient follow-up along with pharmacological and non-pharmacological methods. Some minor additions and changes have been made to the ASAS/EULAR recommendations. All of the recommendations had sufficient strength. Conclusion: National recommendations for the management of AS were developed based on scientific evidence and consensus expert opinion. These recommendations will be updated regularly in accordance with recent developments.en_US
dc.description.abstractTürkiye Romatizma Araştırma ve Savaş Derneği᾽nin (TRASD) Ankilozan Spondilit (AS) için ulusal tedavi önerilerinin oluşturulmasıdır. Gereç ve yöntemler: TRASD tarafından altı Romatoloji ve 19 Fiziksel Tıp ve Rehabilitasyon uzmanı olmak üzere toplam 25 kişiden oluşan bir bilimsel kurul oluşturuldu. Önerilerde 2006 yılında yayınlanan Ankilozan Spondilit Değerlendirme Uluslararası Çalışma Grubu (ASAS)/Romatizmaya karşı Avrupa Ligi (EULAR) önerileri ve Ocak 2005 - Eylül 2010 arasında yayınlanmış olan ilişkili yayınlar konusundaki sistematik bir inceleme temel alındı. Öneriler oluşturulurken Delphi süreci kullanıldı. Ankilozan spondilit tedavisi ile ilgili 12 ana öneri oluşturuldu. Oylama yapılarak önerilerin güçlülük düzeyi bir nümerik derecelendirme skalası ile belirlendi. Bulgular: On iki öneri hasta değerlendirilmesini, hasta takibini ve farmakolojik ve non-farmakolojik yöntemleri içermektedir. ASAS/EULAR önerilerine bazı ilaveler ve önerilerde bazı küçük değişiklikler yapılmıştır. Tüm öneriler yeterli kuvvete sahipti. Sonuç: Bilimsel kanıtlar ve uzmanların görüş birliği ile AS tedavisine yönelik ulusal öneriler oluşturulmuştur. Bu öneriler, yeni gelişmeler doğrultusunda düzenli olarak güncellenmelidirtr_TR
dc.identifier.citationBodur, H. vd. (2011). "Turkish league against rheumatism national recommendations for the management of ankylosing spondylitis". Turkish Journal of Rheumatology, 26(3), 173-186.tr_TR
dc.identifier.endpage186tr_TR
dc.identifier.issn1309-0291
dc.identifier.issue3tr_TR
dc.identifier.scopus2-s2.0-80053229571tr_TR
dc.identifier.startpage173tr_TR
dc.identifier.urihttps://doi.org/10.5606/tjr.2011.028
dc.identifier.urihttps://archivesofrheumatology.org/full-text/411
dc.identifier.urihttp://hdl.handle.net/11452/25069
dc.identifier.volume26tr_TR
dc.identifier.wos000295974400002
dc.indexed.scopusScopusen_US
dc.indexed.trdizinTrDizintr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherRomatizmaya Karşı Türk Dili Yayınlarıtr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.collaborationYurt içitr_TR
dc.relation.journalTurkish Journal of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRheumatologyen_US
dc.subjectAnkylosing spondylitisen_US
dc.subjectNational recommendationsen_US
dc.subjectTreatmenten_US
dc.subjectAntitumor-necrosis-factoren_US
dc.subjectClinical-responseen_US
dc.subject2010 Updateen_US
dc.subjectTherapyen_US
dc.subjectArthritisen_US
dc.subjectEfficacyen_US
dc.subjectSafetyen_US
dc.subjectInfliximaben_US
dc.subjectFlaresen_US
dc.subjectRehabilitationen_US
dc.subjectAnkilozan spondilittr_TR
dc.subjectUlusal önerilertr_TR
dc.subjectTedavitr_TR
dc.subject.emtreeAdalimumaben_US
dc.subject.emtreeCelecoxiben_US
dc.subject.emtreeCorticosteroiden_US
dc.subject.emtreeCyclooxygenase 2 inhibitoren_US
dc.subject.emtreeEtanercepten_US
dc.subject.emtreeGlucocorticoiden_US
dc.subject.emtreeGolimumaben_US
dc.subject.emtreeInfliximaben_US
dc.subject.emtreeLeflunomideen_US
dc.subject.emtreeMethotrexateen_US
dc.subject.emtreeNarcotic analgesic agenten_US
dc.subject.emtreeNonsteroid antiinflammatory agenten_US
dc.subject.emtreePlaceboen_US
dc.subject.emtreePrednisoloneen_US
dc.subject.emtreeSalazosulfapyridineen_US
dc.subject.emtreeTumor necrosis factor alpha antibodyen_US
dc.subject.emtreeAnkylosing spondylitisen_US
dc.subject.emtreeArthritisen_US
dc.subject.emtreeBalneotherapyen_US
dc.subject.emtreeCardiotoxicityen_US
dc.subject.emtreeChronic painen_US
dc.subject.emtreeComparative effectivenessen_US
dc.subject.emtreeCrohn diseaseen_US
dc.subject.emtreeDisease associationen_US
dc.subject.emtreeDrug costen_US
dc.subject.emtreeDrug efficacyen_US
dc.subject.emtreeDrug safetyen_US
dc.subject.emtreeEnteritisen_US
dc.subject.emtreeEvidence based medicineen_US
dc.subject.emtreeFibromyalgiaen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeGastrointestinal symptomen_US
dc.subject.emtreeHip arthroplastyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeJoint stiffnessen_US
dc.subject.emtreeKinesiotherapyen_US
dc.subject.emtreeMuscle stiffnessen_US
dc.subject.emtreeNauseaen_US
dc.subject.emtreeNeuropathic painen_US
dc.subject.emtreeOsteopeniaen_US
dc.subject.emtreePainen_US
dc.subject.emtreePain assessmenten_US
dc.subject.emtreePatient assessmenten_US
dc.subject.emtreePatient careen_US
dc.subject.emtreePatient educationen_US
dc.subject.emtreePhantom painen_US
dc.subject.emtreeProcess developmenten_US
dc.subject.emtreeRating scaleen_US
dc.subject.emtreeReviewen_US
dc.subject.emtreeRheumatoid arthritisen_US
dc.subject.emtreeSpinal painen_US
dc.subject.emtreeSpine surgeryen_US
dc.subject.emtreeSystematic reviewen_US
dc.subject.emtreeTranscutaneous nerve stimulationen_US
dc.subject.emtreeTreatment responseen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.emtreeUveitisen_US
dc.subject.emtreeVertebra fractureen_US
dc.subject.emtreeVomitingen_US
dc.subject.scopusAnkylosing Spondylitis; Sacroiliac Joint; Magnetic Resonance Imagingen_US
dc.subject.wosRheumatologyen_US
dc.titleTurkish league against rheumatism national recommendations for the management of ankylosing spondylitisen_US
dc.title.alternativeTürkiye Romatizma Araştırma ve Savaş Derneği ankilozan spondilit ulusal tedavi önerileritr_TR
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Altan_vd_2011.pdf
Size:
419.14 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: